Genmab — December 2013
-
tror også marts er et godt bud. Det kan dog være ansøgningen tager længere tid at behandle fordi de ansøger med alkylatorbehandling dvs. FDA skal også tage stilling til Bendamustine dataene mv.
-
-
JNJ skaffer 19 mia dkk http://www.bloomberg.com/news/2013-12-02/johnson-johnson-said-to-plan-benchmark-bond-sale-in-six-parts.html ....
-
Det er desværre ikke nok til at opkøbe genmab
-
svarer kun til kurs 365
-
Iøvrigt er det jo sådanne aftaler som oncomed aftalen genmab vil lave i fremtiden. 50/50 partnerskaber
-
Aftalen inklusiv upfront har en milestonepakke på 1990 mio. $
-
Bava stiger fordi Genmab køber dem
Genmab falder forbi genmabinvestorerne ved at bavapipelinen er lort 
-
Tillykke til dem der fangede den på bunden og til GS: http://www.youtube.com/watch?v=JIbQbGq-jIE
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind